19th Sep 2008 07:00
RNS Number : 8135D
GlaxoSmithKline PLC
18 September 2008
Quest Diagnostics Inc - Variable Sales Forward Agreements
GlaxoSmithKline plc (GSK) today confirmed that the Variable Sales Forward Agreements (VSF Agreements) with Lehman Brothers Finance S.A., with respect to a total of 20 million shares of common stock of Quest Diagnostics Inc., have terminated with no material financial impact to GSK expected. GSK has requested that the shares, which were pledged under the VSF Agreements and held in custody by Lehman Brothers Inc, be returned to GSK.
Simon Bicknell
Company Secretary
18 September 2008
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Glaxosmithkline